• 1
    Atkins PC, Schwartz LB, Adkinson NF von Allmen C., Valenzano M., Zweiman B. In vivo antigen-induced cutaneous mediator release:simultaneous comparisons of histamine, tryptase, and prostaglandin D2 release and the effect of oral corticosteroid administration. J Allergy Clin Immunol 1990;86:36070.
  • 2
    Baraniuk JN, Kowalski ML, Kaliner MA. Relationships between permeable vessels, nerves, and mast cells in rat cutaneous neurogenic inflammation. J Appl Physiol 1990;68:230511.
  • 3
    Barker JN, Allen MH, MacDonald DM. Alterations induced in normal human skin by in vivo interferon-gamma. Br J Dermatol 1990;122:4518.
  • 4
    Benyon RC. The human skin mast cell. Clin Exp Allergy 1989;19:37587.
  • 5
    Bochner BS. Charlesworth EN, Lichtenstein LM, et al. Interleukin-1 is released at sites of human cutaneous allergic reactions. J Allergy Clin Immunol 1990;86:8309.
  • 6
    Dunn CJ. Hardee MM, Staite ND. Acute and chronic inflammatory responses to local administration of recombinant IL-1 alpha. IL-beta, TNF alpha, IL-2 and IFN gamma in mice. Agents Actions 1989; 27: 2903.
  • 7
    Fleekop PD, Atkins PC von Allmen C., Valenzano MC, Shalit M., Zweiman B. Cellular inflammatory responses in human allergic skin reactions. J Allergy Clin Immunol 1987;80:1406.
  • 8
    Foreman JC. Neuropeptides and the pathogenesis of allergy. Allergy 1987;42:111.
  • 9
    Frew AJ, Kay AB. The relationship between infiltrating CD4 + lymphocytes, activated eosinophils, and the magnitude of the allergen-induced late phase cutaneous reaction in man. J Immunol 1988;141:415864.
  • 10
    Friedman MM. Kaliner M. Ultrastructure of human skin mast cells after antigen-induced degranulation in vivo. J Allergy Clin Immunol 1988;81:297.
  • 11
    Gronneberg R., Dahlen SE. Interactions between histamine and prostanoids in IgE-dependent, late cutaneous reactions in man. J Allergy Clin Immunol 1990;85:84352.
  • 12
    Hamid Q. Ying S. Varney V., et al. Localization of cells expressing mRNA for the cytokine gene cluster, IL-3, IL-4, IL-5 and GM-CSF in allergen-induced cutaneous late-phase reactions in atopic patients. J Allergy Clin Immunol 1991;87:208.
  • 13
    Harper EI, Beck JS, Spence VA. Effect of topically applied local anaesthesia on histamine flare in man measured by laser Doppler velocimetry. Agents Actions 1989;28:1927.
  • 14
    Henocq E., Vargaftig BB. Accumulation of eosinophils in response to intracutaneous PAF-acether and allergen in man. Lancet 1986:i:13789.
  • 15
    Holgate ST, Benyon RC, Lowman MA, Church MK. Activation of human mast cells after immunoglobulin E-dependent and neuropeptide stimulation. Prog Clin Biol Res 1989;297:10312.
  • 16
    Humphrey DM. Inflammatory exudates in skin window induced by l-0-alkyl-2-acetyl-sn-glyceryl 3-phosphoryl-choline. Am J Pathol 1990;136:46777.
  • 17
    Kowalski ML, Sliwinska-Kowalska M., Kaliner MA. Neurogenic inflammation, vascular permeability, and mast cells. II. Additional evidence indicating that mast cells are not involved in neurogenic inflammation. J Immunol 1990; 145: 121421.
  • 18
    Lawrence ID, Warner JA, Cohan VL, et al. Bradykinin analog induces histamine release from human skin mast cells. Adv Exp Med Biol 1989;247A:2259.
  • 19
    Leiferman KM, Fujisawa T., Gray BH, Gleich GJ. Extracellular deposition of eosinophil and neutrophil granule proteins in the IgE-mediated cutaneous late phase reaction. Lab Invest 1990;62:57989.
  • 20
    Luger TA. Epidermal cytokines. Acta Derm Venereol 1989; 151:6176; discussion 106–10.
  • 21
    Michel L., Mencia-Huerta JM, Benveniste J., Dubertret L. Biologic properties of LTB4 and PAF-acether in vivo in human skin. J Invest Dermatol 1987;88:67581.
  • 22
    Montagna W., Carlisle K. Structural changes in ageing skin. Br J Dermatol 1990;122 (suppl. 35):6170.
  • 23
    Reshef A., Kagey-Sobotka A., Adkinson NF Jr, Lichtenstein LM, Norman PS. The pattern and kinetics in human skin of erythema and mediators during the acute and late-phase response (LPR). J Allergy Clin Immunol 1989;84:67887.
  • 24
    Scholz D., Brandt Hofflin K., Hahn HL. Wirkung von rekombinantem Interferon-gamma auf allergische Hautreaktion und Bronchokonstriktion. Pneumologie 1990;44 (suppl. 1):4312.
  • 25
    Schwartz LB. Mast cell heterogeneity with special attention to cutaneous atopic disease. Allergy 1989;44 (suppl. 9):3540.
  • 26
    Shalit M., Campbell DE von Allmen C., Atkins PC, Douglas SD, Zweiman B. Neutrophil activation in human inflammatory skin reactions. J Allergy Clin Immunol 1987;80:8793.
  • 27
    Shalit M., Schwartz LB von Allmen C., Atkins PC, Lavker RM, Zweiman B. Release of histamine and tryptase during continuous and interrupted cutaneous challenge with allergen in humans. J Allergy Clin Immunol 1990;86:11725.
  • 28
    Shalit M., Valone FH, Atkins P., Goetzl EJ, Zweiman B. Platelet activating factor release in allergic sites in humans. J Allergy Clin Immunol 1987;79:248.
  • 29
    Warner JA, Pienkovski MM, Plaut M., Norman PS, Lichtenstein LM. Identification of histamine releasing factors) in the late phase of cutaneous IgE-mediated reactions. J Immunol 1986;136:25837.
  • 30
    Wollard PM, Cunningham FM, Murphy GM, Camp RD, Derm FF, Greaves MW. A comparison of the proinflammatory effects of 12(R and 12(S)-hydroxy-5, 8, 10, 14-eicosatetraenoic acid in human skin. Prostaglandins 1989;38:46571.
  • 31
    Zweiman B. Mediators of allergic reactions in the skin. Clin Allergy 1988;18:41935.